HEALTHCARE TRAINING 2021 - 6-Hour Virtual Seminar on EU Regulatory Affairs strategy during development of medicinal products
Website https://www.gcplearning.com/virtual-seminar/6-hour-virtual-seminar-on-eu-regulatory-affairs-strategy |
Edit Freely
Category HEALTHCARE TRAINING 2021
Deadline: February 25, 2021 | Date: February 25, 2021
Venue/Country: Online event, U.S.A
Updated: 2021-01-06 23:31:15 (GMT+9)
Call For Papers - CFP
The main document from a regulatory perspective in the development of a medicinal product is the regulatory plan. In this Seminar it is explained how to write the regulatory plan, and which aspects to consider.The regulatory plan describes the regulatory strategy, as well as pricing and reimbursement issues in your development.Orphan Medicinal Products will be discussed, and the advantages of having a status as an orphan medicinal product will be explained. Incentives for the development of orphan medicinal products have been available in the United States of America since 1983 and in Japan since 1993, and also the EU offers a range of incentives to encourage the development of these medicines.Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.